about
Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndromeSpecificities of platelet autoantibodies and platelet activation in lupus anticoagulant patients: a relation to their history of thromboembolic disease.Pregnancy-associated recurrent liver necrosis in patient with antiphospholipid syndrome.Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic toleranceAntiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.Antiphospholipid Syndrome during pregnancy: the state of the artExcessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.Competence and competition: the challenge of becoming a long-lived plasma cell.Annexin A2: biology and relevance to the antiphospholipid syndrome.Basic mechanisms and pathogenesis of venous thrombosis.Pathophysiology of thrombotic APS: where do we stand?The antiphospholipid syndrome: from pathophysiology to treatment.Effects of anti-β2-glycoprotein I antibody on PlGF, VEGF and sVEGFR1 production from cultured choriocarcinoma cell line.Cytokines associated with increased erythropoiesis in Sprague-Dawley rats administered a novel hyperglycosylated analog of recombinant human erythropoietin.IgA antiphospholipid antibodies are an independent risk factor for thromboses.In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies.Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.Obstetric antiphospholipid syndromeAcute adrenal insufficiency due to adrenal hemorrhage complicating colorectal surgery: Report of two cases and correlation with the antiphospholipid antibody syndrome
P2860
Q24185813-2B1F2DEF-3A9C-44D7-9AA8-D18F50AD0E73Q33372491-2CB6CCC8-4688-4EF0-8C88-E80B8DB74701Q33373807-B319097F-B61C-46CD-9200-6B1B73020432Q33591736-5AC74719-7B44-49DA-B671-BB571E0C7BE4Q35070716-EB5068A1-5241-4DF1-8017-834599BA1D9FQ35756040-1AE8A818-5A2F-490C-AB68-ABC6EE820B12Q36470411-C5317427-8AA6-4EE1-B27E-C2D368A54D4AQ36594883-9A93B449-B594-4FD0-830E-67592D81236AQ37283042-3F6AF3B9-1822-4591-A5DC-3E4166F79B11Q37388336-C4C5D1CE-D45F-4E63-96EF-E6DF94FBF5A7Q38013582-E1EC6825-F35F-4E17-99C2-5C903DB68C19Q38873953-CA081977-A248-43D4-93BD-449CFED20CBBQ39557076-7C366C0C-ECB2-495B-AF4C-6DD8769F5BADQ43748919-B871C34E-2FC6-49CD-8C78-60FC030A092DQ46318776-DA3D16E7-C839-460D-AC66-782F3200CB74Q46982839-7430F2CC-3916-4DFE-902C-1A96491E36BAQ53560316-A3B4F5E6-561B-471D-BF48-47067D38A4D2Q58551653-B370958C-FF5A-43C1-9D0E-FECBAC5C38AAQ58768948-B3C9899D-A504-4E8D-AA57-0FD795C6A63B
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pathophysiology of the antiphospholipid syndrome
@ast
Pathophysiology of the antiphospholipid syndrome
@en
Pathophysiology of the antiphospholipid syndrome
@nl
type
label
Pathophysiology of the antiphospholipid syndrome
@ast
Pathophysiology of the antiphospholipid syndrome
@en
Pathophysiology of the antiphospholipid syndrome
@nl
prefLabel
Pathophysiology of the antiphospholipid syndrome
@ast
Pathophysiology of the antiphospholipid syndrome
@en
Pathophysiology of the antiphospholipid syndrome
@nl
P2860
P1476
Pathophysiology of the antiphospholipid syndrome
@en
P2093
P G de Groot
P2860
P304
P356
10.1111/J.1538-7836.2005.01359.X
P407
P577
2005-08-01T00:00:00Z